{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:31:51Z","timestamp":1777671111464,"version":"3.51.4"},"reference-count":46,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2019,9,17]]},"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>The World Health Organization (WHO) recommends that countries implement pharmacovigilance and collect information on active drug safety monitoring (aDSM) and management of adverse events.<\/jats:p><jats:p>The aim of this prospective study was to evaluate the frequency and severity of adverse events to anti-tuberculosis (TB) drugs in a cohort of consecutive TB patients treated with new (<jats:italic>i.e.<\/jats:italic>bedaquiline, delamanid) and repurposed (<jats:italic>i.e.<\/jats:italic>clofazimine, linezolid) drugs, based on the WHO aDSM project. Adverse events were collected prospectively after attribution to a specific drug together with demographic, bacteriological, radiological and clinical information at diagnosis and during therapy. This interim analysis included patients who completed or were still on treatment at time of data collection.<\/jats:p><jats:p>Globally, 45 centres from 26 countries\/regions reported 658 patients (68.7% male, 4.4% HIV co-infected) treated as follows: 87.7% with bedaquiline, 18.4% with delamanid (6.1% with both), 81.5% with linezolid and 32.4% with clofazimine. Overall, 504 adverse event episodes were reported: 447 (88.7%) were classified as minor (grade 1\u20132) and 57 (11.3%) as serious (grade 3\u20135). The majority of the 57 serious adverse events reported by 55 patients (51 out of 57, 89.5%) ultimately resolved. Among patients reporting serious adverse events, some drugs held responsible were discontinued: bedaquiline in 0.35% (two out of 577), delamanid in 0.8% (one out of 121), linezolid in 1.9% (10 out of 536) and clofazimine in 1.4% (three out of 213) of patients. Serious adverse events were reported in 6.9% (nine out of 131) of patients treated with amikacin, 0.4% (one out of 221) with ethionamide\/prothionamide, 2.8% (15 out of 536) with linezolid and 1.8% (eight out of 498) with cycloserine\/terizidone.<\/jats:p><jats:p>The aDSM study provided valuable information, but implementation needs scaling-up to support patient-centred care.<\/jats:p>","DOI":"10.1183\/13993003.01522-2019","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T18:37:30Z","timestamp":1570732650000},"page":"1901522","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":138,"title":["Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report"],"prefix":"10.1183","volume":"54","author":[{"given":"Sergey","family":"Borisov","sequence":"first","affiliation":[]},{"given":"Edvardas","family":"Danila","sequence":"additional","affiliation":[]},{"given":"Andrei","family":"Maryandyshev","sequence":"additional","affiliation":[]},{"given":"Margareth","family":"Dalcolmo","sequence":"additional","affiliation":[]},{"given":"Skaidrius","family":"Miliauskas","sequence":"additional","affiliation":[]},{"given":"Liga","family":"Kuksa","sequence":"additional","affiliation":[]},{"given":"Selene","family":"Manga","sequence":"additional","affiliation":[]},{"given":"Alena","family":"Skrahina","sequence":"additional","affiliation":[]},{"given":"Saulius","family":"Diktanas","sequence":"additional","affiliation":[]},{"given":"Luigi Ruffo","family":"Codecasa","sequence":"additional","affiliation":[]},{"given":"Alena","family":"Aleksa","sequence":"additional","affiliation":[]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[]},{"given":"Antoniya","family":"Koleva","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Piubello","sequence":"additional","affiliation":[]},{"given":"Zarir Farokh","family":"Udwadia","sequence":"additional","affiliation":[]},{"given":"Onno W.","family":"Akkerman","sequence":"additional","affiliation":[]},{"given":"Evgeny","family":"Belilovski","sequence":"additional","affiliation":[]},{"given":"Enrique","family":"Bernal","sequence":"additional","affiliation":[]},{"given":"Martin J.","family":"Boeree","sequence":"additional","affiliation":[]},{"given":"Julen","family":"Cadi\u00f1anos Loidi","sequence":"additional","affiliation":[]},{"given":"Qingshan","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Jose Joaqu\u00edn","family":"Cebrian Gallardo","sequence":"additional","affiliation":[]},{"given":"Masoud","family":"Dara","sequence":"additional","affiliation":[]},{"given":"Edita","family":"Davidavi\u010dien\u0117","sequence":"additional","affiliation":[]},{"given":"Lina Davies","family":"Forsman","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4400-5447","authenticated-orcid":false,"given":"Jorge","family":"De Los Rios","sequence":"additional","affiliation":[]},{"given":"Justin","family":"Denholm","sequence":"additional","affiliation":[]},{"given":"Jacinta","family":"Drak\u0161ien\u0117","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Seifeldin Eltaeb","family":"Elamin","sequence":"additional","affiliation":[]},{"given":"Nadia","family":"Escobar Salinas","sequence":"additional","affiliation":[]},{"given":"Maurizio","family":"Ferrarese","sequence":"additional","affiliation":[]},{"given":"Alexey","family":"Filippov","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Garcia","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2809-6230","authenticated-orcid":false,"given":"Jos\u00e9-Mar\u00eda","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[]},{"given":"Ieva","family":"Gaudiesiute","sequence":"additional","affiliation":[]},{"given":"Blagovesta","family":"Gavazova","sequence":"additional","affiliation":[]},{"given":"Regina","family":"Gayoso","sequence":"additional","affiliation":[]},{"given":"Roscio","family":"Gomez Rosso","sequence":"additional","affiliation":[]},{"given":"Vygantas","family":"Gruslys","sequence":"additional","affiliation":[]},{"given":"Gina","family":"Gualano","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1007-1075","authenticated-orcid":false,"given":"Wouter","family":"Hoefsloot","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-6176","authenticated-orcid":false,"given":"Jerker","family":"Jonsson","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Khimova","sequence":"additional","affiliation":[]},{"given":"Heinke","family":"Kunst","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"Laniado-Labor\u00edn","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[]},{"given":"Cecile","family":"Magis-Escurra","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-5109","authenticated-orcid":false,"given":"Vinicio","family":"Manfrin","sequence":"additional","affiliation":[]},{"given":"Valentina","family":"Marchese","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Mart\u00ednez Robles","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Matteelli","sequence":"additional","affiliation":[]},{"given":"Jesica","family":"Mazza-Stalder","sequence":"additional","affiliation":[]},{"given":"Charalampos","family":"Moschos","sequence":"additional","affiliation":[]},{"given":"Marcela","family":"Mu\u00f1oz-Torrico","sequence":"additional","affiliation":[]},{"given":"Hamdan","family":"Mustafa Hamdan","sequence":"additional","affiliation":[]},{"given":"Birut\u0117","family":"Nak\u010derien\u0117","sequence":"additional","affiliation":[]},{"given":"Laurent","family":"Nicod","sequence":"additional","affiliation":[]},{"given":"Magnolia","family":"Nieto Marcos","sequence":"additional","affiliation":[]},{"given":"Domingo Juan","family":"Palmero","sequence":"additional","affiliation":[]},{"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[]},{"given":"Apostolos","family":"Papavasileiou","sequence":"additional","affiliation":[]},{"given":"Marie-Christine","family":"Payen","sequence":"additional","affiliation":[]},{"given":"Agostina","family":"Pontarelli","sequence":"additional","affiliation":[]},{"given":"Sarai","family":"Quir\u00f3s","sequence":"additional","affiliation":[]},{"given":"Adrian","family":"Rendon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-9367","authenticated-orcid":false,"given":"Laura","family":"Saderi","sequence":"additional","affiliation":[]},{"given":"Agnese","family":"\u0160mite","sequence":"additional","affiliation":[]},{"given":"Ivan","family":"Solovic","sequence":"additional","affiliation":[]},{"given":"Mahamadou Bassirou","family":"Souleymane","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Tadolini","sequence":"additional","affiliation":[]},{"given":"Martin","family":"van den Boom","sequence":"additional","affiliation":[]},{"given":"Marisa","family":"Vescovo","sequence":"additional","affiliation":[]},{"given":"Pietro","family":"Viggiani","sequence":"additional","affiliation":[]},{"given":"Askar","family":"Yedilbayev","sequence":"additional","affiliation":[]},{"given":"Rolandas","family":"Zablockis","sequence":"additional","affiliation":[]},{"given":"Dmitry","family":"Zhurkin","sequence":"additional","affiliation":[]},{"given":"Matteo","family":"Zignol","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2298-1623","authenticated-orcid":false,"given":"Dina","family":"Visca","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Spanevello","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 A.","family":"Caminero","sequence":"additional","affiliation":[]},{"given":"Jan-Willem","family":"Alffenaar","sequence":"additional","affiliation":[]},{"given":"Simon","family":"Tiberi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8551-3598","authenticated-orcid":false,"given":"Rosella","family":"Centis","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-5777","authenticated-orcid":false,"given":"Lia","family":"D'Ambrosio","sequence":"additional","affiliation":[]},{"given":"Emanuele","family":"Pontali","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1600-4474","authenticated-orcid":false,"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-574X","authenticated-orcid":false,"given":"Giovanni Battista","family":"Migliori","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"2024102101120168000_54.6.1901522.1","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2018 . Geneva, WHO, 2018. Document WHO\/CDS\/TB\/2018.20."},{"key":"2024102101120168000_54.6.1901522.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0035-2019"},{"key":"2024102101120168000_54.6.1901522.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00391-2019"},{"key":"2024102101120168000_54.6.1901522.4","first-page":"1382","article-title":"Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative","volume":"8","author":"Nathanson","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102101120168000_54.6.1901522.5","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijid.2019.01.040","article-title":"Challenging MDR-TB clinical problems \u2013 the case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs","volume":"80S","author":"Tiberi","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2024102101120168000_54.6.1901522.6","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO). WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment. Geneva, WHO, 2019. WHO\/CDS\/TB\/2019.3.","DOI":"10.4103\/ijmr.IJMR_579_19"},{"key":"2024102101120168000_54.6.1901522.7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciy990","article-title":"Evolution of programmatic definitions used in tuberculosis prevention and care","volume":"68","author":"Migliori","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024102101120168000_54.6.1901522.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313865"},{"key":"2024102101120168000_54.6.1901522.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00724-2015"},{"key":"2024102101120168000_54.6.1901522.10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00387-2017"},{"key":"2024102101120168000_54.6.1901522.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01891-2015"},{"key":"2024102101120168000_54.6.1901522.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00146-2017"},{"key":"2024102101120168000_54.6.1901522.13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3201\/eid2505.181823","article-title":"Outcomes of bedaquiline treatment in patients with multidrug-resistant tuberculosis","volume":"25","author":"Mbuagbaw","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2024102101120168000_54.6.1901522.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01528-2018"},{"key":"2024102101120168000_54.6.1901522.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112433"},{"key":"2024102101120168000_54.6.1901522.16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02467-2017"},{"key":"2024102101120168000_54.6.1901522.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01105-2017"},{"key":"2024102101120168000_54.6.1901522.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00017-2018"},{"key":"2024102101120168000_54.6.1901522.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31644-1"},{"key":"2024102101120168000_54.6.1901522.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00022912"},{"key":"2024102101120168000_54.6.1901522.21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00035114"},{"key":"2024102101120168000_54.6.1901522.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02445-2016"},{"key":"2024102101120168000_54.6.1901522.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02146-2015"},{"key":"2024102101120168000_54.6.1901522.24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00214-2016"},{"key":"2024102101120168000_54.6.1901522.25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw088"},{"key":"2024102101120168000_54.6.1901522.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01462-2017"},{"key":"2024102101120168000_54.6.1901522.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00934-2018"},{"key":"2024102101120168000_54.6.1901522.28","unstructured":"World Health Organization (WHO). Active TB Drug-Safety Monitoring and Management (aDSM) . WHO\/HTM\/TB\/2015.28. Geneva, WHO, 2015."},{"key":"2024102101120168000_54.6.1901522.29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01643-2017"},{"key":"2024102101120168000_54.6.1901522.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.03.036"},{"key":"2024102101120168000_54.6.1901522.31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1590\/s1806-37562018000000279","article-title":"Global TB Network: working together to eliminate tuberculosis","volume":"44","author":"Rossato Silva","year":"2018","journal-title":"J Bras Pneumol"},{"key":"2024102101120168000_54.6.1901522.32","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCadverse event) Version 5.0, November 2017. Date last accessed: July 28, 2019. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf."},{"key":"2024102101120168000_54.6.1901522.33","unstructured":"R Core Team. R: A language and environment for statistical computing . Vienna, Austria , R Foundation for Statistical Computing, 2018. Data last accessed: July 28, 2019. www.R-project.org"},{"issue":"Suppl. 3","key":"2024102101120168000_54.6.1901522.34","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1093\/cid\/ciy625","article-title":"Linezolid-based regimens for multidrug-resistant tuberculosis (TB): a systematic review to establish or revise the current recommended dose for TB treatment","volume":"67","author":"Bolhuis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024102101120168000_54.6.1901522.35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00751-17"},{"key":"2024102101120168000_54.6.1901522.36","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ebiom.2015.09.051","article-title":"Linezolid trough concentrations correlate with mitochondrial toxicity-related adverse events in the treatment of chronic extensively drug-resistant tuberculosis","volume":"2","author":"Song","year":"2015","journal-title":"EBioMedicine"},{"key":"2024102101120168000_54.6.1901522.37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-2600(18)30426-0","article-title":"Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial","volume":"7","author":"von Groote-Bidlingmaier","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102101120168000_54.6.1901522.38","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00537-2018"},{"key":"2024102101120168000_54.6.1901522.39","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.5588\/ijtld.18.0423","article-title":"QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment","volume":"22","author":"Monedero-Recuero","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102101120168000_54.6.1901522.40","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2024102101120168000_54.6.1901522.41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/009286158401800315","article-title":"The Yale algorithm. Special workshop \u2013 clinical","volume":"18","author":"Kramer","year":"1984","journal-title":"Drug Inf J"},{"key":"2024102101120168000_54.6.1901522.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811867"},{"key":"2024102101120168000_54.6.1901522.43","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe1902904","article-title":"A short regimen for rifampin-resistant tuberculosis","volume":"380","author":"Churchyard","year":"2019","journal-title":"N Engl J Med"},{"key":"2024102101120168000_54.6.1901522.44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1806-37562016000000226","article-title":"Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?","volume":"42","author":"Mu\u00f1oz-Torrico","year":"2016","journal-title":"J Bras Pneumol"},{"key":"2024102101120168000_54.6.1901522.45","doi-asserted-by":"crossref","first-page":"e20180324","DOI":"10.1590\/1806-3713\/e20180324","article-title":"Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation","volume":"45","author":"Tiberi","year":"2019","journal-title":"J Bras Pneumol"},{"key":"2024102101120168000_54.6.1901522.46","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02184-2018"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01522-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:24:08Z","timestamp":1740381848000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01522-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,12,19]]},"published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1183\/13993003.01522-2019"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01522-2019","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]}}}